申请人:Pfizer Inc.
公开号:US04224329A1
公开(公告)日:1980-09-23
2-Substituted-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles of the formula (I): ##STR1## and the pharmaceutically-acceptable salts thereof, wherein the hydrogen atoms in the 4a position and 9b positions are in a trans relationship to each other and the 5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indole moiety is dextrorotatory; X.sub.1 and Y.sub.1 are the same or different and are each hydrogen or fluoro; Z.sub.1 is hydrogen, fluoro or methoxy; M is a member selected from the group consisting of ##STR2## a mixture thereof and C.dbd.O and n is 3 or 4; their use as tranquilizing agents, pharmaceutical compositions containing them and a process for their production.
2-取代-5-芳基-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-b]吲哚的化学式(I)如下:##STR1##及其药用可接受的盐,其中4a位置和9b位置的氢原子相对于彼此是反式的,而5-芳基-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-b]吲哚基团是右旋的;X.sub.1和Y.sub.1相同或不同,分别是氢或氟;Z.sub.1是氢、氟或甲氧基;M是从下列组中选择的成员之一##STR2##或其混合物和C.dbd.O,n为3或4;它们作为镇静剂的用途,含有它们的药物组合物以及它们的生产方法。